Use of Merck's Gardasil and GlaxoSmithKline's Cervarix has cut infection rates in half from the human papillomavirus (HPV) in US teenage females 14-19 years since routine vaccination with the products began in 2006, researchers from the US Centers for Disease Control and Prevention (CDC) reported on 19 June, with the head of the agency calling that outcome "striking."
Use of Merck's Gardasil and GlaxoSmithKline's Cervarix has cut infection rates in half from the human papillomavirus (HPV) in US teenage females 14-19 years since routine vaccination with the products began in 2006, researchers from the US Centers for Disease Control and Prevention (CDC) reported on 19 June, with the head of the agency calling that outcome "striking."
"The bottom line," said CDC Director Dr Tom Frieden, is the types of HPV targeted by the vaccines decreased by...
"Neque porro quisquam est qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit..."
PolyPid's D-PLEX100 meets Phase III endpoints this time around, significantly reducing surgical point infections in abdominal colorectal surgery, and is set for a US approval submission early next year.
The company will ramp up manufacturing of its Jynneos vaccine to meet demand in worst-affected African countries and stockpiling richer nations.
2030 sales forecasts for Novo’s obesity hope are an order of magnitude larger than its closest rival among 2025’s expected debutantes.
"Neque porro quisquam est qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit..."
Pipelines in bioconjugates continue to develop, from ADCs to XDCs, with radionuclide drug conjugates (RDCs) and antibody-oligonucleotide conjugates (AOCs) leading the expansion.
Interim results from the Phase III REMARK study presented at WCLC showed the Chinese company’s second-generation ALK/ROS1 inhibitor met its primary endpoint as a first-line therapy in ALK-positive advanced NSCLC.
![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
